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JUN transcription factors bind DNA as part of the AP-1 complex, regulate many cellular processes, and play a key role in onco-
genesis. The three JUN proteins (c-JUN, JUNB, and JUND) can have both redundant and unique functions depending on the
biological phenotype and cell type assayed. Mechanisms that allow this dynamic switching between overlapping and distinct
functions are unclear. Here we demonstrate that JUND has a role in prostate cell migration that is the opposite of c-JUN’s and
JUNB’s. RNA sequencing reveals that opposing regulation by c-JUN and JUND defines a subset of AP-1 target genes with cell
migration roles. cis-regulatory elements for only this subset of targets were enriched for ETS factor binding, indicating a specific-
ity mechanism. Interestingly, the function of c-JUN and JUND in prostate cell migration switched when we compared cells with
an inactive versus an active RAS/extracellular signal-regulated kinase (ERK) signaling pathway. We show that this switch is due
to phosphorylation and activation of JUND by ERK. Thus, the ETS/AP-1 sequence defines a unique gene expression program
regulated by the relative levels of JUN proteins and RAS/ERK signaling. This work provides a rationale for how transcription
factors can have distinct roles depending on the signaling status and the biological function in question.
Most transcription factors can be grouped into families basedon homologous DNA binding domains (1). These proteins
often bind similar DNA sequences and therefore can compete to
occupy genomic binding sites. Altering the balance of this compe-
tition toward factors with stronger, or weaker, transactivation
functions is onemechanismofmodulating gene expression.How-
ever, this complicates our understanding of individual transcrip-
tion factor function, as a protein that activates transcription in one
cellmay attenuate transcription in a different cell depending upon
the presence of other, stronger activators. Furthermore, signaling
pathways can change the transactivation potential of transcription
factors, thus dynamically altering the roles of competing factors.
In the postgenomic era, where most cis-regulatory sequences are
known, predicting the variable functions of a transcription factor
binding site is a major new challenge.
The AP-1 transcription factor is an important regulator of cel-
lular proliferation, survival, and locomotion and plays a central
role in oncogenesis (2). AP-1 is a dimer of bZIP proteins from the
JUN and FOS families that bind the consensus DNA sequence
5=-TGA(C/G)TCA-3=. JUN proteins can bind as either homo- or
heterodimers, while FOS proteins can bind only DNA as het-
erodimers with JUN. Other bZIP families (ATF, MAF) can also
pair with JUN, but this usually changes the DNA sequence pref-
erence. Once bound to DNA, each JUN family member has dif-
ferent and often antagonistic transcriptional functions (3, 4). Fur-
thermore, the role of JUNmembers changes in different cell types.
For example, c-JUN can promote apoptosis in fibroblasts and
neurons but inhibits apoptosis in hepatocytes and keratinocytes
(3). JUNB and JUND can either promote or inhibit cell cycle pro-
gression depending on the cellular background (5–7). The mech-
anisms that regulate these functional differences are not clear,
making it difficult to predict the role of anAP-1 binding site in any
particular cell type.
AP-1 can work together with a variety of other transcription
factors, including those of the 28-member ETS family (8). Neigh-
boring binding sites for ETS and AP-1 transcription factors were
first identified in viral enhancers (9) and in the promoters of genes
critical for cellularmigration and invasion, including extracellular
protease genes, such as PLAU, MMP1, and MMP9 (10–12). To-
gether but not individually, the ETS and AP-1 binding sequences
confer RAS/extracellular signal-regulated kinase (ERK) pathway
responsiveness to neighboring genes (9, 13). ERK has been shown
to mediate this function via either direct or indirect phosphoryla-
tion of various ETS proteins, such as ETS1, ETS2, ETV1, ETV4,
and ETV5 (14, 15). This phosphorylation event can increase the
affinity of ETS1 for the coactivator CBP/p300 and result in in-
creased transcription of a neighboring gene (16). We recently
identified another role for ETS proteins at these ETS/AP-1 se-
quences (17). In some prostate cancers, a chromosomal rear-
rangement results in the expression of one of four ETS genes
(ERG, ETV1, ETV4, and ETV5) that are not normally expressed in
prostate cells (18). These ETS proteins are oncogenic and promote
prostate cell migration and invasion. We have shown that these
oncogenic ETS proteins bind ETS/AP-1 sequences throughout the
genome and activate transcription in the absence of RAS/ERK
pathway activation (17). Therefore, we proposed twomechanisms
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of ETS function at ETS/AP-1 sequences. First, RAS/ERK-respon-
sive ETS proteins can bind and activate transcription only when
the RAS/ERK pathway is active. Second, oncogenic ETS pro-
teins can bind and activate transcription in the absence of RAS/
ERK signaling. While we have models for ETS function at ETS/
AP-1 sequences, little is known about the role of AP-1 at this
critical RAS/ERK response element.
Here we test the roles of the three JUN family members in
regulating the cell migration transcriptional programmediated
by ETS/AP-1 sequences. We find in prostate cell lines where
RAS/ERK signaling is low that c-JUN promotes cell migration
but that JUND inhibits migration. Interestingly, using tran-
scriptome-wide RNA-sequencing (RNA-seq), we find that
both c-JUN and JUND activate the majority of AP-1 target
genes but that a subset of target genes are regulated in an op-
posite manner by c-JUN and JUND. This subset is enriched for
cell migration genes and the ETS/AP-1 binding sequence. This
indicates that the ETS/AP-1 sequence defines a gene expression
program regulated in opposite directions by c-JUN and JUND.
Surprisingly, the roles of JUN proteins are completely reversed
in prostate cell lines that have an active RAS/ERK pathway. We
show that the reason for this functional switch stems from the
ability of ERK to bind and phosphorylate JUND, and we pro-
pose that this changes JUND from a weaker activator than c-
JUN into a stronger activator than c-JUN. Therefore, these
findings provide a mechanistic rationale for antagonistic func-
tions of transcription factor family members that can be altered
by RAS/ERK signaling.
MATERIALS AND METHODS
Cell culture and viral transduction. All cell lines used in this study were
authenticated by the University of Arizona Genetics Core using the
PowerPlex 16HS assay (Promega) with a80%match to eight core short
tandom repeat (STR) loci (19). Cell lines were cultured according to
ATCC recommendations as follows: 293 EBNA, HEK293T, and DU145
cells with Dulbecco’s modified Eagle’s medium (DMEM, Sigma) with
10% fetal bovine serum (FBS; Sigma); RWPE (RWPE1) andRWPE-KRAS
(RWPE2) cells with keratinocyte serum-free medium (SFM) with growth
supplements (Invitrogen); and PC3 cells with F12Kmedium (Mediatech-
Cellgro) with 10% FBS. All media were supplemented with 1% penicillin-
streptomycin (100 solution; Mediatech-Cellgro). Lentivirus for JUN
knockdown experiments were produced by cotransfection of pLKO.1
constructs encoding short-hairpin RNAs (shRNAs) in HEK293T cells
with pMDLg/pRRE, pRSV-Rev, and pMD2.G envelope plasmids (Add-
gene). shRNA sequences were luciferase, CTTACGCTGAGTACTTCGA
TTC; c-JUN, AAGGAAGCTGGAGAGAATCGC (20); JUNB, AAGCAAC
GGCGTGATCACGAC (21); and JUND, ACGCGAACCTGAGCAGC
TATT (22). Full-length JUN open reading frames were cloned into the
vector pQCXIH (Clontech) using oligonucleotides indicated in Table S2
in the supplemental material. JUN proteins were stably expressed in
DU145 and PC3 cell lines via use of a retrovirus as described previously
(17).
Transwell migration, in vitro scratch, and luciferase assays. Tran-
swell-migration assays were done as described previously (17). In brief,
5 104 cells were introduced to Transwells (8-m pore size; BD Biosci-
ence) and incubated for 48 h (DU145 and PC3) and 60 h (RWPE1,
RWPE-KRAS). Themean of results for five representative fields permem-
brane was determined in each biological replicate. For in vitro scratch
assays, cells were plated in 35-mmplates and grown to full confluence, and
the cultureswere scratchedwith a pipette tip.Migration into the open area
was documented at 24 h postscratching by microscopy. Free area was
measured using TScratch software (23; www.cse-lab.ethz.ch/software
.html). Luciferase assays usingwild-type andmutant ETS/AP-1 sequences
were done in the cell lines indicated above using vectors and methods
previously reported (24).
Measuring protein and RNA levels. Total protein extract from equal
numbers of cells were separated on 10% SDS-PAGE gels and transferred
to nitrocellulose membranes by standard procedures (Bio-Rad). Mem-
branes were blocked in 5% milk in TBS (10 mM Tris, pH 8.0, 150 mM
NaCl), incubated with primary and secondary antibodies, and visualized
by enhanced chemiluminescence (ECL) (Thermo Scientific) by using
standard procedures. Antibodies for c-Jun (sc-45), JunB (sc-8051), and
JunD (sc-74) were from Santa Cruz Biotechnology. Phospho-c-Jun (Ser
73, 9164) was from Cell Signaling. Antitubulin was bought from Sigma.
RNA levels were measured by reverse transcription-quantitative PCR
(RT-qPCR) as previously reported (17). Standard curves from diluted
PCR products were used to measure absolute values for each gene prod-
uct, and then each reading was standardized to the level of a housekeeping
gene (EEF1A). Oligonucleotides used in RT-qPCR are described in Table
S2 in the supplemental material.
ChIP, protein purification, and in vitro kinase assays. Chromatin
immunoprecipitation (ChIP) from PC3 cells was done as previously re-
ported (25) using a JUND antibody from Santa Cruz Biotechnology
(sc-74). qPCR measurement of ChIP enrichment used the primers in
Table S2 in the supplemental material. JUN proteins were cloned into the
pet28a vector, which adds an N-terminal 6His tag. After expression in
BL-21 cells, protein was extracted and JUN proteins were purified by a Ni
chromatography column. Each purified JUN protein could specifically
bind the AP-1 sequence in a gel shift assay. c-JUN N-terminal kinase
(JNK) and ERK2 kinases were from SignalChem. Reaction mixtures con-
tained 0.5 ng/l kinase and 25 ng/l JUN protein and were incubated for
30 min at 30°C.
RNA sequencing. Raw and processed RNA-seq files are available for
download fromNCBI’s Gene ExpressionOmnibus (http://www.ncbi.nlm
.nih.gov/geo) (see below). Total RNA from three biological replicates was
isolated from PC3 cells transduced with lentiviral shRNA knockdown
vectors using the RNeasy minikit (Qiagen) according to the manufactur-
er’s instructions. Sequencing libraries for whole-transcriptome analysis
were generated using a modified Illumina TruSeq sample preparation
protocol. Total RNA was treated with TURBO DNase (Invitrogen). The
DNase-treated RNA was poly(A) selected with oligo(dT) beads (Invitro-
gen). A Superscript III reverse transcriptase first-strand synthesis (Invit-
rogen) systemwas used to generate cDNA from the poly(A)-selected RNA
with randomhexamer primers (Invitrogen). After first-strand synthesis, a
second strand was generated using Escherichia coliDNA ligase (New Eng-
land BioLabs) and E. coliDNA polymerase I (New England BioLabs). The
double-stranded cDNAs were sheared to150 nucleotides using a Diag-
enode Bioruptor, and the size was confirmed by DNA gel electrophoresis.
DNA end repair of the cDNA was performed using Klenow DNA poly-
merase (New England BioLabs), T4 DNA polymerase (New England Bio-
Labs), and T4 DNA ligase (New England BioLabs) before the sample was
subjected to QIAquick PCR purification (Qiagen). Adapters were ligated
to DNA fragments using T4 DNA ligase (New England BioLabs). The
product was run on a 2% agarose gel, size selected to be between 200 and
300 nucleotides, and then purified by a gel extraction kit (Qiagen). Uni-
versal and indexing adapters were taken from the TruSeq sample prepa-
ration kit (Illumina). Deep sequencing was performed on an Illumina
HiSeq2000 instrument according to the manufacturer’s protocol.
Informatics analysis of RNA-seq. The Tuxedo Suite RNA sequencing
pipeline was used to determine differential gene expression for PC3 Jun
knockdown samples sent for deep sequencing as described previously
(26), with some modifications. Raw FASTQ files were mapped to the
human genome (UCSC release, version 19) using TopHat2 with Bowtie2.
The annotated genome file used in the pipeline was modified to contain
gene identifiers as well as transcript identifiers and to remove all noncod-
ing RNA. Differential expression of genes and transcripts was determined
using Cuffdiff2. The RNA-seq data were separated into quadrants based
on gene expression changes in JUND and c-JUN knockdown cells in a
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comparison with that in luciferase knockdown cells. Only genes with
nearest-neighbor JUND-bound regions in PC3 cells (17) were considered
for further analysis. JUND-bound regions near genes in each quadrant
were searched for the sequence MGGAAGW using the Regulatory Se-
quence Analysis Tools (RSAT) DNA pattern function (27; http://rsat.ulb
.ac.be/) and were found to overlap ETV4-bound regions in PC3 cells (17).
The genes from each quadrantwere used as inputs for gene ontology using
the program g:GOSt Gene Group Functional Profiling on g:Profiler (28;
http://biit.cs.ut.ee/gprofiler/index.cgi). The default settings for g:GOSt
were changed to search for only significant ontologies (P  0.05). The
significance threshold for each ontology category was determined using
the Benjamini-Hochberg false-discovery rate. To eliminate broad unin-
formative categories, a maximum of 2,000 genes was set for the ontology
category to be considered.
Microarray data accession number.RawandprocessedRNA-seqfiles
are available for download from the Gene Expression Omnibus database
(http://www.ncbi.nlm.nih.gov/geo) under accession number GSE53470.
RESULTS
JUN family transcription factors have opposing functions in the
regulation of cell migration. ETS/AP-1 binding sequences regu-
late cell migration genes and therefore play a role in the transition
from neoplasia to invasive carcinoma. However, the function of
individual AP-1 subunits at these sites is not known. Because JUN
but not FOS family members have been shown to interact with
various ETS proteins (29), we focused on the role of JUN family
members on cell migration. Lentiviral constructs stably expressed
shRNAs to knock down expression of each JUN familymember in
PC3 prostate cancer cells (Fig. 1A). Each knockdown specifically
changed the expression of the target JUN protein but not those of
the other family members. Loss of either c-JUN or JUNB resulted
in a significant decrease in cell migration in a transwell assay (Fig.
1B and C), indicating that c-JUN and JUNB promote cell migra-
tion. Loss of JUND had the opposite effect, increasing cell mi-
gration (Fig. 1B and C), indicating that JUND is an inhibitor of
cell migration. A second method of measuring cell migration,
the scratch assay, revealed a similar trend (Fig. 1D). None of the
JUN knockdown experiments significantly changed the prolif-
eration rate of PC3 cells (Fig. 1E), indicating that differences in
proliferation do not bias the migration assays. We next tested
the effect of changing the relative levels of JUN proteins by
overexpression. Each JUN protein was stably overexpressed in
PC3 cells by a retroviral vector (Fig. 1F). Overexpression of
c-JUN significantly increased cell migration, and JUNB over-
expression resulted in a similar trend (Fig. 1G and H), consis-
tent with an activating function. Overexpression of JUND sig-
nificantly decreased cell migration (Fig. 1G and H), consistent
with a repressive function. Unlike with their opposite roles in
migration, overexpression of all three JUNs slightly decreased
PC3 proliferation (Fig. 1I). In summary, both depletion and
overexpression experiments indicate that, in PC3 cells, c-JUN
and JUNB activate a cell migration gene expression program
but that JUND has the opposite function.
JUN protein competition for ETS-AP-1 binding sites can ex-
plain opposing cell migration roles. JUN family members bind
the sameDNA sequences in vitro (2) and therefore are predicted to
compete for the same targets in vivo. To verify this, we compared
genome-wide mapping findings from ENCODE (30) for c-JUN,
JUND, and JUNB occupancy in the only cell line for which these
datawere available, K562 (Fig. 2A). Consistentlywith in vitrofind-
ings, the JUNproteins occupied a highly overlapping set of regions
in vivo. To test whether JUN protein occupancy varies by expres-
sion level, chromatin was immunoprecipitated with a JUND an-
tibody fromPC3 cells with either JUNDoverexpression or shRNA
depletion of JUND or c-JUN. Enrichment compared to that of
unbound control loci was measured by quantitative PCR for four
JUND target enhancers randomly selected from a JUND ChIP-
DNA sequencing (ChIP-seq) data set (17). Enrichment at JUND
target enhancers varied from 1.5- to 17-fold (Fig. 2B). In all four
cases, overexpression of JUND increased JUND occupancy, indi-
cating that JUND occupancy was not saturated at these sites (Fig.
2B). At all four targets, shRNA depletion of JUND resulted in a
trend toward less enrichment. Also at all four targets, shRNA
depletion of c-JUN resulted in a trend of increased JUND en-
richment, consistent with competition between these factors.
Therefore, we hypothesized that JUN proteins compete for oc-
cupancy of ETS/AP-1 sequences near cell migration genes. If
c-JUN and JUNB are better activators than JUND in PC3 cells,
this competition may account for their opposite roles observed
in cell migration. To test whether ETS/AP-1 sequences could
indeed mediate these opposite transcriptional functions, a re-
porter construct that has three copies of the ETS/AP-1 se-
quence controlling transcription of the firefly luciferase gene
was tested. This reporter requires both the ETS and AP-1 se-
quences for activation (Fig. 2C). Expression of the reporter in
PC3 cells with JUN knocked down mirrored the cell migration
data, with loss of c-JUN and JUNB significantly reducing lucif-
erase levels and loss of JUND resulting in a trend toward in-
creased luciferase expression (Fig. 2D). Therefore, JUN family
members have antagonistic functions at ETS/AP-1 sequences
that match their cell migration functions.
Genes regulated in opposite manners by c-JUN and JUND
represent a subset of AP-1 targets with roles in cellular locomo-
tion.Previousmapping of AP-1 targets by JUNDChIP-seq in PC3
cells identified enrichment of an AP-1 binding sequence but not
an ETS sequence (17). Ontology analysis of all AP-1 direct target
genes does not identify cell migration functions. These data indi-
cate that ETS/AP-1 cis-regulatory elements and cell migration
genes represent a small subset of all AP-1 targets. Our cell migra-
tion and reporter data (Fig. 1 and 2) are consistent with amodel in
which c-JUN (and, to a lesser extent, JUNB) can activate cell mi-
gration genes via ETS/AP-1 sequences and in which JUND re-
presses, or attenuates, transcription of the same genes. To identify
the gene expression program that follows this pattern, mRNA lev-
els in PC3 cell lineswith c-JUNor JUNDknocked downby shRNA
were compared to mRNA levels in control cells (shRNA targeting
luciferase) using next-generation sequencing. The Tuxedo Suite
(26) was used to quantify mRNA levels from three biologically
independent RNA-seq replicates for each sample. To identify po-
tential direct AP-1 target genes, we analyzed only genes for which
our previous PC3 ChIP-seq data (17) identified a neighboring
JUND-bound region (see Table S1 in the supplemental material).
These direct AP-1 target genes were separated into four categories,
downregulated in both c-JUN and JUND knockdown experi-
ments, upregulated in both, or downregulated in one and upregu-
lated in the other (Fig. 3A). As a control, expression changes for 14
target genes selected for cell migration and roles in epithelial-to-
mesenchymal transition (EMT) were tested by reverse transcrip-
tion-quantitative PCR (RT-qPCR), and 26 of 28 changes identi-
fied by RNA-seq were confirmed (Fig. 3B). The majority of genes
(73%) were in the quadrant downregulated by both c-JUN and
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JUND knockdown (Fig. 3A, lower left), suggesting a common
activating function of these two JUN proteins at most AP-1 tar-
gets. However, we predicted that genes that promote cell migra-
tion would decrease in the c-JUN knockdown experiment and
increase in the JUND knockdown experiment. There were 91 pre-
dicted direct target genes in this quadrant (Fig. 3A, lower right).
The eight genes with the largest expression changes in this quad-
rant are marked in red in Fig. 3A and listed in Table 1. Strikingly,
these eight genes encode three matrix metalloproteases, PLAU,
MMP9, and ADAM19, a metalloprotease inhibitor, SERPINE1,
and signaling ligands FGF1 and PTHLH, all factors involved in
cell migration and/or communication with the tumor mi-
croenvironment (31–33). To test whether the 91 genes in this
quadrant share functions consistent with the cell migration
phenotype, unbiased gene ontology analysis was used (Table
2). The four most overrepresented functional categories of
genes in this quadrant were “extracellular matrix organiza-
tion,” “extracellular structure organization,” “locomotion,”
and “cellular component movement,” consistent with cell mi-
gration and invasion roles. No other quadrant was enriched for
these categories. A directed search found that 31% of the genes
in the lower right quadrant have a role in cellular locomotion,
representing a significant (P 0.01) enrichment over the 15 to
18% of genes in each of the other quadrants (Fig. 3A). In com-
parison, there was no enrichment of genes with a role in cellular
proliferation, consistent with the lack of a proliferation pheno-
FIG 1 JUND and c-JUN/JUNB have opposite functions in PC3 cell migration. (A) Immunoblots with the indicated antibodies (left) show c-JUN, JUNB, and
JUND protein levels in PC3 cell lines expressing shRNAs targeting the indicated genes (top). Tubulin levels provide a loading control. (B) A transwell assay
measured the cell migration of c-JUN-, JUNB-, and JUND-depleted PC3 cells. The relative numbers of cells that migrated are the means and standard errors of
themeans (SEM) from three biological replicates (each value is themean of results from two technical replicates) relative to numbers in a control luciferase (Luc)
knockdown experiment. (C) Representative images of transwell migration assays shown in panel B. (D) The fractions of scratches filled in 24 h bymigrating PC3
cells with shRNAs with the indicated genes knocked down are shown as the means and SEM from five replicates relative to the fraction of the scratch filled in the
control luciferase knockdown experiment. (E) A 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay measured proliferation of
PC3 cells with the indicated genes knocked down by determining absorbance (Abs.) at 600 nM beginning 24 h after plating. The results are the means and SEM
from two biological replicates (each value is the mean of results from three technical replicates). (F) Immunoblots show Jun protein levels in PC3 cells stably
overexpressing the indicated genes (top). (G, H) A transwell assay measured cell migration in PC3 cells with the indicated overexpression of a JUN protein. The
number ofmigrated cells is shown as in panels B andC. (I) Proliferation of PC3 cells overexpressing the indicated JUNprotein is shown as in panel E. All P values
were calculated by the t test (*, P 0.05; **, P 0.005).
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type (Fig. 1E). Therefore, we conclude that opposite regulation
by c-JUN and JUND can define a unique subset of AP-1 target
genes that function to control cellular migration and reorgani-
zation of the extracellular matrix.
Opposite regulation by c-JUN and JUND identifies AP-1 tar-
gets with ETS/AP-1 binding sequences. PLAU and MMP9 are
among the best-documented ETS/AP-1 target genes (10, 11). To
test whether the 89 genes that coregulated with PLAU andMMP9
in the RNA-seq data represent a subset of AP-1 target genes that
are distinguished by ETS/AP-1 binding sequences, an unbiased
search identified the most overrepresented sequence motifs in all
JUND-bound regions (Fig. 3A). As expected, the first motif iden-
tified in all four quadrants matched an AP-1 consensus binding
sequence (TGA[C/G]TCA). However, the secondmotif identified
in each quadrant differed. Significantly, a motif matching an ETS
binding sequence (AGGAAG) was the second-most overrepre-
sented in the quadrant associated with the cell migration pheno-
type (Fig. 3A, lower right), and this motif was not identified as
significantly enriched in any of the other three quadrants (Fig. 3A
and data not shown). The AGGAAG motif is consistent with an
enhancer-enriched binding motif that can be bound by multiple
ETS factors (17, 34). A directed search for the ETS sequence (MG
GAAGW) found it to be significantly enriched among genes in the
lower right quadrant compared to the other three quadrants (Fig.
3A). We have previously reported that PC3 cells overexpress the
oncogenic ETS protein ETV4 and that ETV4 binds ETS/AP-1 se-
quences (17, 35). To test whether ETV4 binding was enriched at
genes that were activated by c-JUN and repressed by JUND, we
examined our previously published PC3 cell ETV4 ChIP-seq data
(17). ETV4-bound regions overlapped JUND-bound regions sig-
nificantly more often when the JUND-bound region was near a
gene in the lower right quadrant than near the other three quad-
FIG 2 JUN protein transcriptional regulation through ETS/AP-1 sequences mirrors migration phenotypes. (A) A Venn diagram indicates overlaps of genomic
regions bound by c-JUN (GSM1003609; Snyder Lab, Stanford University), GFP-JUNB, and GFP-JUND (GSM777638 and GSM777639; White Lab, University
of Chicago) in K562 cells. The number in parentheses indicates the randomly predicted overlap, assuming that all open chromatin regions in K562 cells are
potential accessible binding sites. (B) Chromatin immunoprecipitation (ChIP) of JUND in PC3 cells with the indicated overexpression or knockdown shRNA.
The absolute quantity for each indicated locus was measured by quantitative PCR and is shown as a ratio to the mean quantity of two negative-control loci, such
that values greater than 1 are considered enriched. The means and SEM from two independent replicates are shown for overexpression and from five replicates
for knockdown shRNAs. P values were calculated by the t test (*, P 0.05; **, P 0.005). (C) A firefly luciferase reporter with either three copies of the ETS/AP-1
sequence or point mutations in the ETS or AP-1 sequences, as indicated, cloned upstream of a minimal promoter was transfected into PC3 cells. The ratio of
firefly to renilla (control) luciferase is shown as a mean and SEM of results from three biological replicates relative to the wild-type ETS/AP-1 sequence. (D) The
wild-type ETS/AP-1 reporter was transfected into PC3 cells with the indicated knockdown shRNAs, and reporter activity is shown as in panel C. P values were
calculated by t test (*, P 0.05; **, P 0.001).
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rants (Fig. 3A). Together, the RNA-seq analysis data indicate that
JUN proteins regulate multiple gene expression programs and
that the specific program that is activated by c-JUN and attenu-
ated by JUND in PC3 cells correlates with the presence of ETS/
AP-1 sequences and occupancy of an oncogenic ETS transcription
factor.
The roles of c-JUN and JUND in cell migration switch when
the RAS/ERK pathway is activated. To test whether the ability of
c-JUN and JUNB to activate, and JUND to attenuate, cell migra-
tion is specific to the PC3 cell line, each JUN family member
was knocked down in a second prostate cancer cell line, DU145
(Fig. 4A). Surprisingly, the transwell assay with DU145 cells
showed a result exactly opposite to that with PC3 cells. In DU145
cells, JUNDwas an activator of cell migration (a trend toward loss
of migration in the knockdown experiment), and both c-JUN and
JUNB were repressors of cell migration (Fig. 4B and C). Further-
more, compared to findings with PC3 cells, knockdown of c-JUN
and JUND in DU145 cells had the opposite effect on the expres-
sion of four out of five target genes tested (compare Fig. 3B to 4D).
As in PC3 cells, overexpression of each JUNprotein inDU145 cells
(Fig. 4E) confirmed the knockdown results, with JUND increasing
cell migration and c-JUN and JUNB trending toward decreased
FIG 3 Genes activated by c-JUN and repressed by JUND have ETS/AP-1 motifs and migration roles. (A) A dot plot shows 1,147 genes with nearest-
neighbor JUND-bound regions and with a log2 fold change of0.1 read per kilobase per million (RPKM) in both c-JUN- and JUND-depleted PC3 cells.
Genes listed in Table 1 are marked in red in the dot plot. JUND-bound regions from each quadrant were used to query RSAT (52) to identify
overrepresented sequence motifs. Position weight matrices for the first (above)- and second (below)-most-significant motifs returned are shown as logos
on either side of the dot plot. Genes in each quadrant were compared to a list of genes involved in locomotion, chemotaxis, and extracellular matrix
organization (Locomotion) or genes involved in proliferation as categorized by AmiGO v1.8 (53). The fraction of genes in these ontologies compared to
the total number of genes in the quadrant is shown. Each JUND-bound region was searched for the ETS binding motif MGGAAGW (M A/C;W A/T).
The fraction of bound regions containing this site relative to the total number of genes in each quadrant is shown. JUND-bound regions were compared
to ETV4-bound regions in the same cell line (PC3). The fraction of overlapping regions compared to the total number of genes in each quadrant is shown.
P values are calculated by chi-square testing (*, P  0.01 [depleted]; **, P  0.001 [enriched]). (B) Reverse transcription-quantitative PCR (RT-qPCR)
confirmation of selected RNA-seq (seq) expression changes. Log2 fold changes in the activation of the indicated knockdown shRNAs from the activation
of the knockdown control (luciferase) are shown as means from at least two replicates.
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migration (Fig. 4F and G). Changing JUN levels in DU145 cells
also did not affect proliferation (Fig. 4H and I). So, inDU145 cells,
the role of JUN transcription factors in the cell migration pheno-
type is completely reversed from that in PC3 cells (Fig. 1).
We have previously shown that both RAS/ERK pathway acti-
vation and oncogenic ETS expression can promote cell migration,
but not synergistically (24). PC3 cells express an oncogenic ETS
protein (ETV4) but have low levels of ERK activation, while
DU145 cells have high ERK activity and lack an oncogenic ETS
protein (24). To determine if this difference alone could explain
the altered role of the JUN family transcription factors, we sought
to compare JUN functions in otherwise isogenic cell lines where
the only difference was oncogenic ETS expression or RAS/ERK
activation. RWPE1 cells are derived from normal prostate cells
and exhibit little cell migration (36). Stable overexpression of ei-
ther the oncogenic Kirsten RAS (kiRAS) (RWPE-KRAS) or the
oncogenic ETS protein ERG (RWPE-ERG) induces cell migration
(24). ChIP indicated that JUNDbound target sites in each of these
cell lines (Fig. 5A). We knocked down all three JUN proteins in
both RWPE-ERG and RWPE-KRAS cells (Fig. 5B and C) and
measured cell migration (Fig. 5D to G). The changes in cell mi-
gration in RWPE-ERG cells were the same as those in PC3 cells
(compare Fig. 5D to 1B), and changes in RWPE-KRAS cells mir-
rored those in DU145 cells (compare Fig. 5F to 4B). As with the
other cell lines, no significant change in proliferationwas observed
(Fig. 5H and I). Therefore, c-JUN and JUNB increasemigration in
cells with oncogenic ETS expression (PC3 and RWPE-ERG),
while JUND increases migration in cells with RAS/ERK pathway
activation (DU145 and RWPE-KRAS).
ERK phosphorylation switches JUND to an activator of cell
migration. To explain the differences between c-JUN and JUND,
we hypothesized that either c-JUN requires the presence of an
TABLE 1 Extracellular proteases and growth factors are activated by
c-JUN and repressed by JUND in PC3 cells
Ranka
Gene
identifier Name
Presence of:
ETV4b MGGAAGWc
1 FGF1 Fibroblast growth factor 1 Yes Yes
2 PTPN5 Tyrosine protein
phosphatase nonreceptor
type 5
No Yes
3 ADAM19 Disintegrin and
metalloproteinase domain
protein 19
Yes Yes
4 SERPINE1 Plasminogen activator
inhibitor 1
Yes Yes
5 CXCR7 C-X-C chemokine receptor
type 7
No No
6 MMP9 Matrix metalloproteinase 9 No No
7 PLAU Urokinase-type plasminogen
activator
Yes Yes
8 PTHLH Parathyroid hormone-
related protein
Yes Yes
a The top eight genes with the largest combined decreases in c-JUN repression and
increases in JUND repression in PC3 cells are shown.
b The presence of a neighboring ETV4-bound region was determined by ChIP-seq and
reported by Hollenhorst et al. (17).
c Presence of the ETS consensus sequence in a neighboring JUND-bound region.
TABLE 2 AP-1 target genes activated by c-JUN and repressed by JUND in PC3 cells are enriched for ontologies associated with cell migration and
invasion
Quadranta No. of genes Most overrepresented ontology P value
c-JUN act, JUND rep 91 Extracellular-matrix organization 4.96E08
Extracellular-structure organization 5.12E08
Locomotion 2.70E06
Cellular-component movementc 3.67E06
Epithelium development 5.03E05
Tissue morphogenesis 5.44E05
Positive regulation of phosphorus metabolic process 1.36E04
Morphogenesis of an epithelium 2.40E04
c-JUN act, JUND act 832 Phospholipid binding 2.80E16
Lipid binding 6.13E15
Positive regulation of the RNA metabolic process 8.97E15
Positive regulation of transcription (DNA dependent) 1.10E14
Positive regulation of gene expression 1.11E14
Positive regulation of the nitrogen compound metabolic process 2.89E13
Positive regulation of the nucleobase compound metabolic process 3.30E13
Positive regulation of the macromolecule biosynthetic process 7.15E13
c-JUN rep, JUND actb 51 PI3K-Akt signaling pathway 3.94E03
Regulation of the actin cytoskeleton 3.40E02
c-JUN rep, JUND rep 173 Anatomical-structure formation involved in morphogenesis 2.11E07
Morphogenesis of an epithelium 6.43E07
Tissue morphogenesis 7.73E07
Tube development 7.78E07
Tube morphogenesis 1.31E06
Odontogenesis 1.96E06
Chordate embryonic development 2.52E06
Morphogenesis of embryonic epithelium 2.56E06
a The top eight most enriched ontologies for genes either activated (act) or repressed (rep) by c-JUN and JUND are shown.
b This category had only two ontologies, for which the P value was less than 0.1.
c Cellular-component movement encompasses cell migration and neuronal projections.
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oncogenic ETS to be an activator of migration or JUND requires
an activated RAS/ERK pathway to activate migration. To differ-
entiate these models, we overexpressed each JUN family member
in a cell line that does not express an oncogenic ETS protein or
have an activated RAS/ERK pathway: RWPE1 (Fig. 6A). c-JUN,
but not JUND, increased the cell migration of RWPE1 cells (Fig.
6B andC). This indicates that c-JUNdoes not require the presence
of an oncogenic ETS protein, but JUND does require an activated
RAS/ERK pathway to increase migration. In a reciprocal experi-
ment, c-JUN and JUND were depleted by shRNA in RWPE cells
expressing both oncogenic KRAS and ERG (Fig. 6D), and migra-
tion assays were performed by transwellmigration (Fig. 6E and F).
The RWPE-KRAS-ERG cells showed a migration response that
was similar to that of RWPE-KRAS cells and the opposite of that of
RWPE-ERG cells (compare Fig. 6 and 5), indicating that KRAS
signaling, and not the oncogenic ETS, is the important factor dif-
ferentiating c-JUN and JUND functions.
All three JUN proteins have D domains that mediate binding
and phosphorylation by the mitogen-activated protein kinase
(MAPK) JNK. Consistently with this, we found that JNK could
phosphorylate purified recombinant versions of each JUNprotein
(Fig. 7A). However, JUND also has a docking site for ERK, the
FXFP (DEF) domain (sequence FLYP). A previous study showed
that this DEF domain allowed JUND but not c-JUN to be effi-
ciently phosphorylated by ERK in response to epidermal growth
factor (EGF) signaling in HEK293 cells (37). Furthermore, ERK
phosphorylation of JUND allows increased transcriptional activa-
tion downstream of EGF signaling (37). Consistently with this
previous finding, we found that JUND, but not c-JUN or JUNB,
was phosphorylated by ERK in vitro (Fig. 7A). Therefore, we pro-
posed a model in which c-JUN is a better activator than JUND in
the absence ofRAS/ERKpathway activationbut thatwhen thepath-
way is active, ERK phosphorylates JUND via the DEF domain and
JUND becomes an even stronger activator than c-JUN (Fig. 7B).
To test whether ERK phosphorylation of JUND is required for
JUND activation of cell migration, we created amutant version of
JUND where the ERK binding motif was changed from FLYP to
AAAP (JUND AAAP). Endogenous ERK was immunoprecipi-
tated with a JUND antibody in DU145 cells with overexpressed
JUND, but the AAAP mutation reduced the interaction of JUND
and ERK (Fig. 7C). Both JUND and JUND AAAP were overex-
pressed at similar levels in DU145 cells, but only JUND was de-
FIG 4 The role of JUN proteins in cell migration is cell line dependent. (A) Immunoblots of DU145 cells expressing shRNAs targeting the indicated genes, with
antibodies listed on left. (B, C) A transwell assay measured the migration of c-JUN, JUNB, and JUND knockdown in DU145 cells as described for Fig. 1B and C.
(D) RT-qPCR of changes in the expression of the indicated genes after c-JUN or JUND knockdown in DU145 cells as described for Fig. 3B. (E) Immunoblots
using the indicated antibodies of DU145 cells overexpressing the indicated JUN proteins by means of a retroviral vector. (F, G) A transwell assay measured the
migration of JUN overexpression in DU145 cells as described for Fig. 1B and C. (H, I) Proliferation of DU145 cells with JUN shRNA repressed (H) or
overexpressed (I) is measured as described for Fig. 1E. P values were calculated by the t test (*, P 0.05).
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tected by an anti-phospho-JUN antibody, indicating that the loss
of ERK binding results in a loss of phosphorylation (Fig. 7D).
Importantly, overexpression of JUND in DU145 cells increased
cellmigration, but overexpression of JUNDAAAPdid not (Fig. 7E
and F). Furthermore, JUND could activate expression of two tar-
get genes, PTHLH and PLAU, but JUND AAAP could not (Fig.
7G). Therefore, we conclude that ERK binding is required for the
role of JUND in cell migration. Together, these data indicate that
RAS/ERK signaling can switch the roles of JUND and c-JUN at the
ETS/AP-1 sequences that regulate cell migration. Therefore, both
the relative expression levels of JUN proteins and the level of RAS/
ERK signaling combine to dynamically regulate a gene expression
program critical to cancer progression.
DISCUSSION
AP-1 is a critical regulator of many aspects of cellular behavior;
however, the myriad of subunits that can constitute this dimeric
transcription factor make it difficult to dissect functional mecha-
nisms. We have focused on the role of AP-1 subunits from the
JUN family and identified a gene expression program controlling
cell migration that is regulated in opposite manners by JUND and
c-JUN/JUNB. This program consists of a subset of AP-1-regulated
genes that are defined by the presence of neighboring ETS and
AP-1 binding sequences in cis-regulatory elements. The RAS/ERK
pathway can alter the role of JUN family transcription factors at
these ETS/AP-1 sequences by changing JUND from an attenuator
of the gene expression program to an activator. Together, these
data provide a novel mechanism for how AP-1 transcription fac-
tor functions can vary depending on the relative levels of JUN
family members, the particular gene expression program being
assayed, and the cellular signaling background.
cis-regulatory elements inDNA are collections of transcription
factor binding sequences that together mediate the proper regula-
tion of neighboring genes. JUND and c-JUN had opposite func-
tions at a subset of AP-1 target genes controlled by cis-regulatory
elements with neighboring AP-1 and ETS binding sequences
FIG 5 Oncogenic ETS proteins and RAS/ERK signaling define distinct roles for JUN proteins. (A) ChIP of JUND (as described for Fig. 2B) in the indicated cell
lines, except that means and SEM from three independent replicates are shown. P values compare enrichment to the hypothetical mean of 1 (no enrichment) by
a one-value t test (*, P 0.05; **, P 0.005). (B, C) Immunoblots of RWPE-ERG (B) and RWPE-KRAS (C) cells expressing shRNAs targeting the indicated JUN
genes. (D to G) Transwell assays measured the migration of RWPE-ERG (D, E) and RWPE-KRAS (F, G) cells with c-JUN, JUNB, and JUND knocked down as
described for Fig. 1B and C, except that the means from four replicates are shown. (H, I) Proliferation of RWPE-ERG (H) or RWPE-KRAS (I) cells with JUN
shRNA knocked down is measured as described for Fig. 1E. P values were calculated by the t test (**, P 0.005; ***, P 0.0005).
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(Fig. 3A, lower right). In contrast, JUND and c-JUN share an
activating function when there is an AP-1, but no ETS, binding
sequence (Fig. 3A, lower left). This indicates that the neighboring
ETS protein alters the function of AP-1 and provides an interest-
ing example of a combinatorial code where the function of neigh-
boring transcription factors is different from the simple addition
of each individual function. Many transcription factors have been
shown to activate some targets and repress others in the same cell
(38, 39); however, the cis-regulatory sequences that differentiate
these functions are largely unknown. Here we show that the ETS/
AP-1 sequence motif defines a distinct subset of AP-1 targets
where c-JUN and JUND function antagonistically.
Our data also suggest that the ability of ERK to phosphorylate
JUND and increase transactivation occurs in the context of ETS/
AP-1 targets. ERK can phosphorylate, in addition to JUND, a
number of ETS proteins, such as ETS1 and ETS2 (14). ERK phos-
phorylation increases the affinity of ETS1 and ETS2 for the coacti-
vator, CBP/p300, resulting in increased transactivation (16, 40).
Interestingly, an isolated ETS binding sequence does not confer
ERK responsiveness to a neighboring gene. RAS-responsive ele-
ments consist of either two adjoining ETS binding sequences, such
as those found in the MMP3 promoter (41), or neighboring ETS
and AP-1 binding sequences, such as those found in the MMP9
promoter and PLAU enhancer (10, 11). It is interesting to specu-
late that a cooperative interaction with two phosphorylated tran-
scription factors (either ETS/ETS or ETS/JUND) is required to
efficiently recruit a coactivator, such as CBP/p300, to an enhancer
in a RAS-responsive manner. Although RAS/ERK signaling can
increase the transactivation function of JUND (37, 42), JUND is
known to negatively regulate RAS-mediated cellular transforma-
tion by downregulating cell growth (43). Our findings provide an
explanation for this discrepancy by showing that JUND controls
multiple gene expression programs, and the ETS/AP-1 program
that JUND activates in response to RAS/ERK signaling is associ-
ated with cell migration and not cell proliferation.
We also identify an ETS/JUN combination that allows activa-
tion of cell migration gene expression in the absence of RAS/ERK
signaling. In cells lacking RAS/ERK activity, c-JUN and oncogenic
ETS factors (ERG, ETV1, ETV4, and ETV5) can cooperate to ac-
tivate cell migration genes through ETS/AP-1 sequences. This
finding is consistent with several recent reports that indicate an
important role for c-JUN in both ERG- and ETV1-positive pros-
tate cancer (44, 45). It is interesting that the E3 ubiquitin ligase
COP1 targets ETV1, ETV4, ETV5, and c-JUN (46–48). Loss of
COP1 would allow both oncogenic ETS and c-JUN proteins to be
stabilized and synergistically activate ETS/AP-1 target genes.
The fact that the COP1 gene is deleted or downregulated in
various types of cancer, including prostate cancer (46, 47), pro-
vides a mechanism for upregulation of both oncogenic ETS
proteins and c-JUN. We have recently shown that the ability of
oncogenic ETS proteins, such as ERG, to activate through ETS/
AP-1 sequences requires the phosphoinositol 3-kinase (PI3K)/
AKT pathway (24). A recent report indicates that PI3K/AKT
activation and overexpression of ERG in megakaryocytes in-
creases dependence on c-JUN (49), indicating that synergism
between these factors may extend to other cell types. The JNK
signaling pathway is also known to be a major regulator of
c-JUN function (50), and JNK signaling can cooperate with
PI3K signaling during prostate cancer progression (51). Inter-
esting foci of future work will be the mechanism that allows
c-JUN to work with oncogenic ETS proteins and the contribu-
tions of both JNK and PI3K/AKT signaling to this function.
FIG 6 The switch in JUN functions is due to KRAS signaling. (A) Immunoblots of RWPE1 cells transduced with retroviral vectors expressing the indicated JUN
members. (B, C) A transwell assay measured the migration of RWPE1 cells overexpressing c-JUN, JUNB, and JUND as described for Fig. 1B and C, except that
means and SEM from two replicates are shown relative to values for cells expressing the empty vector. (D) Immunoblots of JUN proteins from RWPE-KRAS-
ERG cells expressing the indicated shRNA. (E, F) Relative migration of cell lines in panel D by transwell assay. All P values were calculated by the t test (*, P
0.05).
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Taken together, these findings suggest that the ETS/AP-1 se-
quence element defines a cell migration gene expression program
that is regulated by ETS and AP-1 transcription factor competi-
tion and mitogenic signaling pathways.
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